APP-FUBINACA

• UNSPSC Description:

  APP-FUBINACA is a cannabinoid receptor agonist and a derivative of phenylalaninamide-based indazole-3-carboxamide. APP-FUBINACA exhibits neurostimulatory effects[1].

• Target Antigen:

  Cannabinoid Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein;Neuronal Signaling

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/app-fubinaca.html

• Smiles:

  NC([C@H](CC1=CC=CC=C1)NC(C2=NN(CC3=CC=C(C=C3)F)C4=CC=CC=C24)=O)=O

• Molecular Weight:

  416.45

• References & Citations:

  [1]Varfaj I, et al. Chromatographic enantioresolution and stereochemical characterization of synthetic cannabinoid receptor agonists with Whelk-O®1 chiral stationary phases under mass spectrometry compatible reversed-phase conditions: A study case with seized samples. Anal Chim Acta. 2024 Aug 15;1317:342901.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1185282-03-4